Voyager Therapeutics gene therapy improves motor function in Parkinson’s patients – STAT
STAT |
Voyager Therapeutics gene therapy improves motor function in Parkinson's patients
STAT gene therapy from Voyager Therapeutics (VYGR 1) delivered surgically into the brains of patients with advanced Parkinson's disease reduced their need for standard Parkinson's medications and improved motor function, according to results from a small, … Voyager Therapeutics posts added proof its gene therapy for Parkinson's can work Voyager Therapeutics Announces Positive Results from Ongoing Phase 1b Trial of VY-AADC01 for Advanced … Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Closed Well Above Its 50 Day Moving Average |
